Patrick McGrady

3.9k total citations
19 papers, 1.5k citations indexed

About

Patrick McGrady is a scholar working on Neurology, Molecular Biology and Cancer Research. According to data from OpenAlex, Patrick McGrady has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Patrick McGrady's work include Neuroblastoma Research and Treatments (18 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer therapeutics and mechanisms (5 papers). Patrick McGrady is often cited by papers focused on Neuroblastoma Research and Treatments (18 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer therapeutics and mechanisms (5 papers). Patrick McGrady collaborates with scholars based in United States, Switzerland and Belgium. Patrick McGrady's co-authors include Wendy B. London, Susan L. Cohn, John M. Maris, Yaël P. Mossé, Katherine K. Matthay, Hiroyuki Shimada, A. Thomas Look, Garrett M. Brodeur, Arlene Naranjo and Robert C. Seeger and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Patrick McGrady

19 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick McGrady United States 16 1.1k 785 610 337 160 19 1.5k
Véronique Laithier France 12 271 0.2× 267 0.3× 138 0.2× 370 1.1× 159 1.0× 27 1.1k
Purificación García‐Miguel Spain 18 123 0.1× 424 0.5× 188 0.3× 292 0.9× 39 0.2× 36 936
Kuiran Dong China 18 117 0.1× 597 0.8× 441 0.7× 152 0.5× 75 0.5× 67 1000
Elena Leonardi Italy 15 73 0.1× 337 0.4× 231 0.4× 519 1.5× 89 0.6× 32 1.0k
Scott C. Bresler United States 10 322 0.3× 290 0.4× 181 0.3× 237 0.7× 78 0.5× 34 603
Isabella Morra Italy 19 78 0.1× 412 0.5× 293 0.5× 296 0.9× 204 1.3× 43 1.2k
Josef Pichler Austria 17 106 0.1× 447 0.6× 210 0.3× 260 0.8× 160 1.0× 55 1.2k
B Devictor France 18 76 0.1× 340 0.4× 156 0.3× 260 0.8× 126 0.8× 39 773
Markus Kreuz Germany 19 134 0.1× 392 0.5× 125 0.2× 392 1.2× 44 0.3× 50 1.0k
Gregor Schulz Germany 14 238 0.2× 272 0.3× 72 0.1× 365 1.1× 42 0.3× 19 792

Countries citing papers authored by Patrick McGrady

Since Specialization
Citations

This map shows the geographic impact of Patrick McGrady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick McGrady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick McGrady more than expected).

Fields of papers citing papers by Patrick McGrady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick McGrady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick McGrady. The network helps show where Patrick McGrady may publish in the future.

Co-authorship network of co-authors of Patrick McGrady

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick McGrady. A scholar is included among the top collaborators of Patrick McGrady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick McGrady. Patrick McGrady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bresler, Scott C., Daniel A. Weiser, Peter J. Huwe, et al.. (2014). ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma. Cancer Cell. 26(5). 682–694. 252 indexed citations
2.
Yanik, Gregory A., Marguerite T. Parisi, Barry L. Shulkin, et al.. (2013). Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group. Journal of Nuclear Medicine. 54(4). 541–548. 133 indexed citations
3.
Seif, Alix E., Arlene Naranjo, David L. Baker, et al.. (2013). A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children’s Oncology Group study ANBL00P1. Bone Marrow Transplantation. 48(7). 947–952. 35 indexed citations
4.
5.
Nuchtern, Jed G., Wendy B. London, Carol E. Barnewolt, et al.. (2012). A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants. Annals of Surgery. 256(4). 573–580. 113 indexed citations
6.
Koyama, Hiroshi, Tiangang Zhuang, Venkatadri Kolla, et al.. (2012). Mechanisms of CHD5 Inactivation in Neuroblastomas. Clinical Cancer Research. 18(6). 1588–1597. 48 indexed citations
7.
Villablanca, Judith G., Wendy B. London, Arlene Naranjo, et al.. (2011). Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group. Clinical Cancer Research. 17(21). 6858–6866. 80 indexed citations
8.
Cohn, Susan L., et al.. (2010). Racial and ethnic disparities in disease presentation and survival among children with neuroblastoma (NBL): A Children's Oncology Group (COG) study.. Journal of Clinical Oncology. 28(15_suppl). 9517–9517. 4 indexed citations
9.
Yanik, Greg, Marguerite T. Parisi, Arlene Naranjo, et al.. (2010). MIBG scoring as a prognostic indicator in patients with stage IV neuroblastoma: A COG study.. Journal of Clinical Oncology. 28(15_suppl). 9516–9516. 4 indexed citations
10.
Henderson, Tara O., Ravi Bhatia, Navin Pinto, et al.. (2010). Racial and Ethnic Disparities in Risk and Survival in Children With Neuroblastoma: A Children's Oncology Group Study. Journal of Clinical Oncology. 29(1). 76–82. 106 indexed citations
11.
Combaret, Valérie, Michael D. Hogarty, Wendy B. London, et al.. (2009). Influence of neuroblastoma stage on serum‐based detection of MYCN amplification. Pediatric Blood & Cancer. 53(3). 329–331. 29 indexed citations
12.
Bray, Isabella, Kenneth Bryan, Patrick G. Buckley, et al.. (2009). Widespread Dysregulation of MiRNAs by MYCN Amplification and Chromosomal Imbalances in Neuroblastoma: Association of miRNA Expression with Survival. PLoS ONE. 4(11). e7850–e7850. 96 indexed citations
13.
Lagmay, Joanne, Wendy B. London, Thomas G. Gross, et al.. (2009). Prognostic Significance of Interleukin-6 Single Nucleotide Polymorphism Genotypes in Neuroblastoma:rs1800795(Promoter) andrs8192284(Receptor). Clinical Cancer Research. 15(16). 5234–5239. 36 indexed citations
14.
Beierle, Elizabeth A., Nicole Massoll, Joseph E. Hartwich, et al.. (2008). Focal Adhesion Kinase Expression in Human Neuroblastoma: Immunohistochemical and Real-time PCR Analyses. Clinical Cancer Research. 14(11). 3299–3305. 51 indexed citations
15.
Miller, Michal A., Kensuke Ohashi, Xiaoyan Zhu, et al.. (2006). Survivin mRNA Levels Are Associated With Biology of Disease and Patient Survival in Neuroblastoma: A Report From the Children's Oncology Group. Journal of Pediatric Hematology/Oncology. 28(7). 412–417. 25 indexed citations
16.
Moreau, Lisa A., Patrick McGrady, Wendy B. London, et al.. (2006). Does MYCN Amplification Manifested as Homogeneously Staining Regions at Diagnosis Predict a Worse Outcome in Children with Neuroblastoma? A Children's Oncology Group Study. Clinical Cancer Research. 12(19). 5693–5697. 23 indexed citations
17.
Attiyeh, Edward F., Wendy B. London, Yaël P. Mossé, et al.. (2005). Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma. New England Journal of Medicine. 353(21). 2243–2253. 395 indexed citations
18.
Attiyeh, Edward F., Yaël P. Mossé, Cynthia Winter, et al.. (2005). Chromosome arm 11q deletion predicts for neuroblastoma outcome: A Children’s Oncology Group study. Journal of Clinical Oncology. 23(16_suppl). 6–6. 14 indexed citations
19.
McGrady, Patrick. (1985). The Availability of a k-out-of-n:G Network. IEEE Transactions on Reliability. R-34(5). 451–452. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Véronique Laithier Breakdown of academic impact, for papers by Purificación García‐Miguel Breakdown of academic impact, for papers by Kuiran Dong Breakdown of academic impact, for papers by Elena Leonardi Breakdown of academic impact, for papers by Scott C. Bresler Breakdown of academic impact, for papers by Isabella Morra Breakdown of academic impact, for papers by Josef Pichler Breakdown of academic impact, for papers by B Devictor Breakdown of academic impact, for papers by Markus Kreuz Breakdown of academic impact, for papers by Gregor Schulz
Rankless by CCL
2026